The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E

Vaccine

Volumn 25, Issue 9, 2007, Pages 1662-1668

  Dong, Chen ^a   Dai, Xing ^a   Meng, Ji Hong ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Combined vaccine; Hepatitis A; Hepatitis E

Indexed keywords

HEALIVE; HEPATITIS A ANTIBODY; HEPATITIS A HEPATITIS E VACCINE; HEPATITIS A VACCINE; HEPATITIS E ANTIBODY; HEPATITIS E VIRUS PROTEIN 179; HEPATITIS VACCINE; INACTIVATED VIRUS VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS E; HEPATITIS E VIRUS; IMMUNIZATION; IMMUNOGENICITY; MONOTHERAPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; VACCINES, COMBINED; VIRAL HEPATITIS VACCINES;

EID: 33846194587     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.11.001     Document Type: Article

References (29)

1. Miller M.J. Summary of current nomenclature, taxonomy and classification of various microbial agents. Clin Infect Dis 16 (1993) 597-615
2. Gust I.D. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 10 Suppl. 1 (1992) S56-S58
3. National surveillance for acute viral hepatitis through 1995. Hepatitis Surveillance Report No. 57. Atlanta, Ga: Centers for Disease Control and Prevention; 2000.
4. Tam A.W., Smith M.M., Guerra M.E., Huang C.C., Bradley D.W., Fry K.E., et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185 (1991) 120-131
5. Bradley D.W. Hepatitis non-A, non-B virus become identified as hepatitis C and E viruses. Prog Med Virol 37 (1990) 101-135
6. Coursaget P., Buisson Y., Enogat N., Bercion R., Baudet J.M., Delmaire P., et al. Outbreak of enterically-transmitted hepatitis due to hepatitis A and hepatitis E viruses. J Hepatol 28 (1998) 745-750
7. Yayli G., Kilic S., and Ormeci A.R. Hepatitis agents with enteric transmission-an epidemiological analysis. Infection 30 (2002) 334-337
8. Orr N., Klement E., Gillis D., Sela T., Kayouf R., Derazne E., et al. Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines. Vaccine 24 (2006) 4328-4332
9. Wang X.Y., Xu Z.Y., Yao X., Tian M.Y., Zhou L.D., He L.F., et al. Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines. Vaccine 22 (2004) 1941-1945
10. Worm H.C., van der Poel W.H., and Brandstätter G. Hepatitis E: an overview. Microbes Infect 4 (2002) 657-666
11. Meng J.H., Pillot J., Dai X., Fields H.A., and Khudyakov Y.E. Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus positive serum samples obtained from different sources. Virology 249 (1998) 316-324
12. Tsarev S.A., Tsareva S.T., Emerson S.U., Govindarajan S., Shapiro M., Gerin J.L., et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 15 (1997) 1834-1838
13. Purcell R.H., Nguyena H., Shapiro M., Engle R.E., Govindarajan S., Blackwelder W.C., et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 21 (2003) 2607-2615
14. Meng J.H., Dai X., Joy C.C., Elena L., Pillot J., Fields H.A., et al. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 288 (2001) 203-211
15. Dong C., and Meng J.H. Expression, purification and immunogenicity of a novel hepatitis E virus-like particle. J. Cell. Mol. Immunol. (Chin.) 22 (2006) 339-342
16. Wolters B., Junge U., Dziuba S., and Roggendorf M. Immunogenicity of combined hepatitis A and B vaccine in elderly persons. Vaccine 21 (2003) 3623-3628
17. Roberton D., Marshall H., Nolan T.M., Sokal E., Diez-Domingo J., Flodmark C.E., et al. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. Vaccine 23 (2005) 5099-5105
18. Van der Wielen M., Van Damme P., Chlibek R., Smetana J., and von Sonnenburg F. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. Vaccine 24 (2006) 5509-5515
19. Ren A., Feng F., Ma J., Xu Y., and Liu C. Immunoegenicity and safety of a new inactivated hepatitis A vaccine in young adults: a comparative study. Chin Med J 115 (2002) 1483-1485
20. Beales L.P., Wood D.J., Minor P.D., and Saldanha J.A. A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies. J Virol Methods 59 (1996) 147-154
21. Obriadina A., Meng J.H., Ulanova T., Trinta K., Burkov A., Fields H.A., et al. A new enzyme immunoassay for the detection of antibody to hepatitis E virus. J Gastroenterol Hepatol 17 (2002) 360-364
22. Minutello M., Zotti C., Orecchia S., Martino E.D., Bastianoni I., Ypma E., et al. Dose range evaluation of a new inactived hepatitis A vaccine administered as a single dose followed by a booster. Vaccine 19 (2001) 10-15
23. Ashur Y., Adler R., Rowe M., and Shouval D. Comparison of immunogenicity of two hepatitis A vaccines - VAQTA and HAVRIX - in young adults. Vaccine 17 (1999) 2290-2296
24. Eskola J., Ward J., Dagan R., Goldblatt D., Zepp F., and Siegrist C.A. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 354 (1999) 2063-2068
25. Punjabi N.H., Richie E.L., Simanjuntak C.H., Harjanto S.J., Wangsasaputra F., Arjoso S., et al. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Vaccine 24 (2006) 1776-1785
26. Bartosch B., Bukh J., Meunier J.C., Granier C., Engle R.E., Blackwelder W.C., et al. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci USA 100 24 (2003) 14199-14204
27. Meng J.H., Dubreuil P., and Pillot J. A new PCR-based seroneutralization assay in cell culture for diagnosis of hepatitis E. J Clin Microbiol 35 (1997) 1373-1377
28. Wong S., and Brown K.E. Development of an improved method of detection of infectious parvovirus B19. J Clin Virol 35 (2006) 407-413
29. Zibert A., Dudziak P., Schreier E., and Roggendorf M. Characterization of antibody response to hepatitis C virus protein E2 and significance of hypervariable region 1-specific antibodies in viral neutralization. Arch Virol 142 (1997) 523-534